Gopal Chandra Saha

Title: Gopal Chandra Saha: Innovator in Pharmaceutical Treatments

Introduction

Gopal Chandra Saha is a notable inventor based in Dublin, California. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hyperuricemia and gout. With a total of six patents to his name, Saha's work has the potential to impact many patients suffering from these conditions.

Latest Patents

One of Saha's latest patents focuses on methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid in conjunction with a second urate-lowering agent. This patent discloses pharmaceutical compositions, methods, and kits designed to lower serum uric acid levels in subjects. The compositions include a first urate-lowering agent, which may be (−)-halofenate, (−)-halofenic acid, or pharmaceutically acceptable salts thereof. Additionally, the second urate-lowering agent can be an inhibitor of uric acid production, a uricosuric agent, a uricase, or a pharmaceutically acceptable salt thereof.

Career Highlights

Throughout his career, Gopal Chandra Saha has worked with various companies, including Cymabay Therapeutics, Inc. and Diatex, Inc. His experience in these organizations has allowed him to develop innovative solutions in the pharmaceutical industry.

Collaborations

Saha has collaborated with notable coworkers such as Brian K Roberts and Brian Edward Lavan. These partnerships have likely contributed to the advancement of his research and patent developments.

Conclusion

Gopal Chandra Saha is a distinguished inventor whose work in pharmaceutical treatments has the potential to improve the lives of many individuals suffering from gout and hyperuricemia. His innovative approaches and collaborations highlight his commitment to advancing medical science.